Opko Health Inc. buy melinda
Start price
27.11.17
/
50%
€4.20
Target price
28.05.18
€6.00
Performance (%)
-23.50%
End price
28.05.18
€3.21
Summary
This prediction ended on 28.05.18 with a price of €3.21. The prediction for Opko Health Inc. disappointed with a performance of -23.50%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Opko Health Inc. | -0.982% | -0.982% | -16.662% | -68.292% |
iShares Core DAX® | 1.051% | -1.833% | 12.822% | 15.392% |
iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% | 42.396% |
iShares Nikkei 225® | -1.778% | -8.115% | 16.092% | 0.891% |
iShares S&P 500 | 0.002% | -2.226% | 28.387% | 41.095% |
Comments by melinda for this prediction
In the thread Opko Health Inc. diskutieren
Pharmazeutische SecteurProduits Agenda 28/02 Ergebnisse Veröffentlichung
OPKO Health, Inc.
OPKO Health registriert seinen ersten Patienten in der Phase 2B von OPK88004 gutartiger Prostatahypertrophie zu behandeln
(Laufzeit überschritten)